Understanding emergence of antimycobacterial dose dependent resistance (2022)
Attributed to:
Dose rationale for antibiotic combination therapy in infection diseases
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1101/2022.09.02.506358
Publication URI: http://dx.doi.org/10.1101/2022.09.02.506358
Type: Preprint